VOLITIONRX LTD — Director's Dealing 2022

Nov 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2022-11-01-05:00

Reporting Person: Plummer Nicholas (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-01-05:00	Common Stock	F	9406	$1.97	Disposed	46694	Direct

Footnotes

F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 21,750 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.